secwatch.observer — SEC 8-K summary
======================================

Issuer:     Albertsons Companies, Inc. (ACI)
CIK:        0001646972
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0001646972-23-000051
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Albertsons Q1: identical sales +4.9%; adj. EPS $0.93 vs $1.00 YoY
-----------------------------------------------------------------

- Net sales $24.1B (+3.4% YoY); identical sales +4.9% driven by inflation, pharmacy, digital.
- Net income $417M ($0.72 EPS); adjusted net income $546M ($0.93 EPS), down from $582M.
- Adjusted EBITDA $1,319M (5.5% margin) vs $1,420M (6.1%); decline due to fewer COVID vaccines.
- Digital sales +22%; loyalty members +16% to 35.9M; capital expenditures $623M for 43 remodels.
- Expects ~$130M headwind to adj. EBITDA from COVID vaccine/test kit decline in remaining quarters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1646972/000164697223000051/0001646972-23-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1646972/000164697223000051/aci-20230725.htm
  HTML page:      https://secwatch.observer/filing/0001646972-23-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer